Skip to content
healthcare.dev

Darunavir 600 and 800 mg

NDC 69097-244, darunavir, tablet, from Cipla USA Inc..

Product NDC
69097-244
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206288
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-244 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DARUNAVIR HYDRATE800 mg/1

Pharmacologic classes

Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; HIV Protease Inhibitors [MoA]; Protease Inhibitor [EPC]

Package NDCNDC-11Package
69097-244-026909702440230 TABLET in 1 BOTTLE (69097-244-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5624cc30-d484-458e-b234-9bb745a118ca
  • NADAC price for package 69097024402

    GET /v1/drugs/nadac/69097024402

Use it

Look up 69097-244 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-244 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-244. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.